Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
Clinical data of participants. Parameter | Control | Obese | * p Value: Vitamin D (nmol/L) | 62.50 | 27 | 68.50 | 0.7 | 0.84
Source: Results table. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Study design awaiting verification.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.
Meta-analysis unclear · Blinding unclear / not reported · Human research reported
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
The participants were recruited between July 2021 and November 2021.
Source: Methods.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Obesity Alters the microRNA Expression Profile Related to Metabolic Disorders in Peripheral Blood Mononuclear Cells: Preliminary Results
Study design awaiting verification · Current Issues in Molecular Biology · 2025
Original publication title
Obesity Alters the microRNA Expression Profile Related to Metabolic Disorders in Peripheral Blood Mononuclear Cells: Preliminary Results
© 2025 by the authors.
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
What does the authors’ abstract report?
Obesity is a major global health issue associated with an increased risk of early-onset metabolic disorders and chronic inflammation. Identifying the epigenetic mechanisms that contribute to obesity-related metabolic and inflammatory dysregulation is crucial for developing effective prevention and treatment strategies. This pilot study aimed to investigate the effects of obesity on the expression of microRNAs (miRNAs) related to metabolic disorders in human peripheral blood mononuclear cells from metabolically healthy obese subjects and non-obese controls. Differentially expressed miRNAs in TaqMan human miRNA arrays were quantified using quantitative PCR.
To validate the robustness and generalizability of our findings, we performed cross-validation using the publicly available GSE155096 dataset. The expression of miR-145-5p was significantly increased (4.913-fold change) in obese individuals compared to the non-obese control group. Two miRNAs, miR-27b-3p and miR-17-5p, were downregulated 2.207: and 1.448-fold, respectively, approaching significance. A positive correlation was established between miR-145-5p and free triiodothyronine, eosinophils, and vitamin D. A cross-validation analysis confirmed the direction of change for these key miRNAs. The data suggest that miR-145-5p, miR-27b-3p, and miR-17-5p could be implicated in the progression of obesity in causing metabolic abnormalities, clarifying how molecular factors cause the metabolic deregulation associated with obesity.
Authors’ abstract
Obesity is a major global health issue associated with an increased risk of early-onset metabolic disorders and chronic inflammation. Identifying the epigenetic mechanisms that contribute to obesity-related metabolic and inflammatory dysregulation is crucial for developing effective prevention and treatment strategies. This pilot study aimed to investigate the effects of obesity on the expression of microRNAs (miRNAs) related to metabolic disorders in human peripheral blood mononuclear cells from metabolically healthy obese subjects and non-obese controls. Differentially expressed miRNAs in TaqMan human miRNA arrays were quantified using quantitative PCR.
To validate the robustness and generalizability of our findings, we performed cross-validation using the publicly available GSE155096 dataset. The expression of miR-145-5p was significantly increased (4.913-fold change) in obese individuals compared to the non-obese control group. Two miRNAs, miR-27b-3p and miR-17-5p, were downregulated 2.207: and 1.448-fold, respectively, approaching significance. A positive correlation was established between miR-145-5p and free triiodothyronine, eosinophils, and vitamin D. A cross-validation analysis confirmed the direction of change for these key miRNAs. The data suggest that miR-145-5p, miR-27b-3p, and miR-17-5p could be implicated in the progression of obesity in causing metabolic abnormalities, clarifying how molecular factors cause the metabolic deregulation associated with obesity.
Publication and source details
Original title: Obesity Alters the microRNA Expression Profile Related to Metabolic Disorders in Peripheral Blood Mononuclear Cells: Preliminary Results
Samar Sultan; Marwah Maashi
Current Issues in Molecular Biology · 2025
* Correspondence: sasultan@kau.edu.sa; Tel.: +966-126400000© 2025 by the authors.2025https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).This research received no external funding.Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-11T01:04:54.024075+00:00
DOI: 10.3390/cimb47100799 · PMC12564426